Literature DB >> 32421785

Prognostic Value of Masked Uncontrolled Hypertension Defined by Different Ambulatory Blood Pressure Criteria.

Francesca Coccina1, Anna M Pierdomenico2, Chiara Cuccurullo2, Jacopo Pizzicannella1, Rosalinda Madonna3, Oriana Trubiani1, Francesco Cipollone2, Sante D Pierdomenico1.   

Abstract

BACKGROUND: Masked uncontrolled hypertension (MUCH), that is, non-hypertensive clinic but high out-of-office blood pressure (BP) in treated patients is at increased cardiovascular risk than controlled hypertension (CH), that is, non-hypertensive clinic and out-of-office BP. Using ambulatory BP, MUCH can be defined as daytime and/or nighttime and/or 24-hour BP above thresholds. It is unclear whether different definitions of MUCH have similar prognostic information. This study assessed the prognostic value of MUCH defined by different ambulatory BP criteria.
METHODS: Cardiovascular events were evaluated in 738 treated hypertensive patients with non-hypertensive clinic BP. Among them, participants were classified as having CH or daytime MUCH (BP >135/85 mm Hg) regardless of nighttime BP (Group 1), nighttime MUCH (BP >120/70 mm Hg) regardless of daytime BP (Group 2), 24-hour MUCH (BP >130/80 mm Hg) regardless of daytime or nighttime BP (Group 3), daytime MUCH only (Group 4), nighttime MUCH only (Group 5) and daytime + nighttime MUCH (Group 6).
RESULTS: We detected 215 (29%), 357 (48.5%), 275 (37%), 42 (5.5%),184 (25%) and 173 (23.5%) patients with MUCH from Group 1 to 6, respectively. During the follow-up (10 ± 5 years), 148 events occurred in patients with CH and MUCH. After adjustment for covariates, compared to patients with CH, the adjusted hazard ratio (95% confidence interval) for cardiovascular events was 2.01 (1.45-2.79), 1.53 (1.09-2.15), 1.69 (1.22-2.34), 1.52 (0.80-2.91), 1.15 (0.74-1.80) and 2.29 (1.53-3.42) from Group 1 to 6, respectively.
CONCLUSIONS: The prognostic impact of MUCH defined according to various ambulatory BP definitions may be different.
© The Author(s) 2020. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd.

Entities:  

Keywords:  blood pressure; classification; hypertension; masked hypertension; risk

Year:  2020        PMID: 32421785     DOI: 10.1093/ajh/hpaa078

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

1.  Epidemiology of arterial hypertension in Tunisia: Hammam Sousse Sahloul Heart Study (HSHS).

Authors:  Aicha Hamoudi; Asma Ben Abdelaziz; Sarra Melki; Donia Ben Hassine; Nabila Ben Rejeb; Asma Omezzine; Ali Bouslama; Ahmed Ben Abdelaziz
Journal:  Tunis Med       Date:  2022 fevrier

2.  Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.

Authors:  Xiaocen Fu; Hong Ren; Jingyuan Xie; Weiming Wang; Yan Li; Pingjin Gao; Nan Chen
Journal:  JAMA Netw Open       Date:  2022-05-02

3.  Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications.

Authors:  Ramón C Hermida; Michael H Smolensky; Horia Balan; Richard J Castriotta; Juan J Crespo; Yaron Dagan; Sherine El-Toukhy; José R Fernández; Garret A FitzGerald; Akio Fujimura; Yong-Jian Geng; Ramón G Hermida-Ayala; Antonio P Machado; Luiz Menna-Barreto; Artemio Mojón; Alfonso Otero; R Daniel Rudic; Eva Schernhammer; Carsten Skarke; Tomoko Y Steen; Martin E Young; Xiaoyun Zhao
Journal:  Chronobiol Int       Date:  2020-12-20       Impact factor: 3.749

4.  Association of clinic and ambulatory blood pressure with new-onset atrial fibrillation: A meta-analysis of observational studies.

Authors:  Francesca Coccina; Anna M Pierdomenico; Matteo De Rosa; Chiara Cuccurullo; Sante D Pierdomenico
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-05       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.